I Gunther Eysenbach %V 13 %N 4 %P e89 %T Anxiety Online-A虚拟诊所;完成焦虑障碍和症状的五种全自动治疗方案的初步结果%A Klein,Britt %A Meyer,Denny %A Austin,David William %A Kyrios,Michael %+国家治疗中心，斯威本大学生命与社会科学学院，Mail H99，邮政信箱218,Hawthorn，墨尔本，3122，澳大利亚，61 392148851，bklein@swin.edu.au %K治疗%K网络干预%K心理健康%K认知行为治疗%K广广性焦虑障碍%K惊恐障碍%K强迫症%K社交焦虑障碍%K创伤后应激障碍%K自助%K全自动%K网络治疗%D 2011年7月11日2011年9月原文%J J医学互联网研究%G英语%X背景:在过去十年中，为治疗或预防精神疾病和增进福祉而开发的电子心理健康干预措施迅速增加。这一发展有助于公众避开在试图获得传统的面对面精神卫生保健服务时经常遇到的一些障碍。目的:我们的研究目的是调查五种全自动自助认知行为电子治疗方案对广泛性焦虑障碍(GAD)、伴或不伴广场恐怖症的恐慌障碍(PD/A)、强迫症(OCD)、创伤后应激障碍(PTSD)和社交焦虑障碍(SAD)的治疗后效果，这些方案通过焦虑在线(一个开放获取的全方位服务的焦虑障碍虚拟心理诊所)向国际公众提供。方法:我们采用自然的参与者选择，准实验设计来评估五个焦虑在线全自动自助电子治疗程序。参与者被要求至少有一种焦虑障碍的亚临床水平，以提供相关的疾病特异性全自动自助电子治疗计划。这些课程都是通过Anxiety Online免费提供的。结果:共有225人自选5种电子治疗方案(GAD, n = 88; SAD, n = 50; PD/A, n = 40; PTSD, n = 30; OCD, n = 17) and completed their 12-week posttreatment assessment. Significant improvements were found on 21/25 measures across the five fully automated self-help programs. At postassessment we observed significant reductions on all five anxiety disorder clinical disorder severity ratings (Cohen d range 0.72–1.22), increased confidence in managing one’s own mental health care (Cohen d range 0.70–1.17), and decreases in the total number of clinical diagnoses (except for the PD/A program, where a positive trend was found) (Cohen d range 0.45–1.08). In addition, we found significant improvements in quality of life for the GAD, OCD, PTSD, and SAD e-therapy programs (Cohen d range 0.11–0.96) and significant reductions relating to general psychological distress levels for the GAD, PD/A, and PTSD e-therapy programs (Cohen d range 0.23–1.16). Overall, treatment satisfaction was good across all five e-therapy programs, and posttreatment assessment completers reported using their e-therapy program an average of 395.60 (SD 272.2) minutes over the 12-week treatment period. Conclusions: Overall, all five fully automated self-help e-therapy programs appear to be delivering promising high-quality outcomes; however, the results require replication. Trial Registration: Australian and New Zealand Clinical Trials Registry ACTRN121611000704998; http://www.anzctr.org.au/trial_view.aspx?ID=336143 (Archived by WebCite at http://www.webcitation.org/618r3wvOG) %M 22057287 %R 10.2196/jmir.1918 %U //www.mybigtv.com/2011/4/e89/ %U https://doi.org/10.2196/jmir.1918 %U http://www.ncbi.nlm.nih.gov/pubmed/22057287